- When making a selection for appropriate ART to initiate in a pregnant female, it is important to consider tolerability, neonatal risk of exposure, pharmacokinetic differences, and overall risk-benefit of each regimen.

- The monitoring of infants with HIV is challenging as there is variability with viral loads and CD4 counts depending on the age.

- Studies have demonstrated that administering zidovudine (ZDV) monotherapy to both the mother and neonate reduces MTCT from 25% to 8% and when combined with other ART the MTCT rate is reduced to less than 1%.

- Repeated negative HIV test results are needed postpartum due to the increased risk of transmission of HIV during labor and delivery.